Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.05% to £19.14 Wednesday, on what proved to be an all-around rough ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million ...

Hikma Pharmaceuticals KSA, announced the expansion of its strategic partnership with the Saudi Gastroenterology Association ...

Both central banks are expected to announce that interest rates will remain unchanged.

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables ...

European stocks closed on a strong note on Thursday with investors cheering the Federal Reserve's decision to cut interest rates by ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Global stock markets experienced an uptick on Tuesday as investors held their breath for the US interest rate decision. The ...

The pan European Stoxx 600 closed with a gain of 1.38 per cent. The UK's FTSE 100 gained 0.91 per cent, Germany's DAX climbed 1.55 per cent, and France's CAC 40 ended up 2.29 per cent, while ...